Killen Group’s Genesco GCO Stock Holding History

Killen Group’s Portfolio GCO Stock Details GCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,000	Closed	-$411K	–	121
2014 Q2	$411K	Sell	5,000 -260	-5%	-$19.9K	0.02%	115
2014 Q1	$392K	Sell	5,260 -74,170	-93%	-$5.39M	0.02%	109
2013 Q4	$5.8M	Sell	79,430 -225	-0.3%	-$15.7K	0.33%	83
2013 Q3	$5.22M	Buy	79,655 +1,310	+2%	+$89.6K	0.31%	89
2013 Q2	$5.25M	Buy	+78,345	New	+$5.04M	0.37%	79

Other funds holding GCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Killen Group's GCO Position: Q3 2014 in Review

Killen Group sold out of Genesco (GCO) in Q3 2014, closing a stake of 5,000 shares — an estimated $411K sold.

Killen Group first reported a position in GCO in Q2 2013 and held it in 5 quarters. The position peaked at $5.8M in Q4 2013. 144 funds tracked by Wall St. Rank hold GCO as of Q3 2014.

Killen Group reported no remaining Genesco position as of Q3 2014 after selling out during the quarter.
Killen Group sold 5,000 Genesco shares in Q3 2014, an estimated $411K.
Killen Group first reported a position in Genesco in Q2 2013 and held it in 5 quarters.
Killen Group's Genesco position peaked at $5.8M in Q4 2013.
144 funds tracked by Wall St. Rank held Genesco as of Q3 2014.

Based on Killen Group's 13F filing for Q3 2014, filed 4 Nov 2014.